Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Rockwell Medical Inc
RMTICurrent price
2.49 USD
-0.17 USD (-6.39%)
Last closed
2.83 USD
Company
www.rockwellmed.com
ISIN
US7743741024
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
137 463 776 USD
Yield for 12 month
+12.67 %
1Y
3Y
5Y
10Y
15Y
RMTI
Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan. Address: 30142 South Wixom road, Wixom, MI, United States, 48393
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7.5 USDP/E ratio
–Dividend Yield
–Current Year
+83 612 000 USD
Last Year
+72 810 000 USD
Current Quarter
+25 832 000 USD
Last Quarter
+22 676 000 USD
Current Year
+8 704 000 USD
Last Year
+4 077 000 USD
Current Quarter
+4 550 000 USD
Last Quarter
+3 064 000 USD
Key Figures RMTI
1 year
3 years
5 years
10 years
EBITDA
-885 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-4.25 %
PEG Ratio
-0.79
Return On Equity TTM
-28.9 %
Wall Street Target Price
7.5 USD
Revenue TTM
94 372 000 USD
Book Value
0.76 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
42.9 %
Dividend Yield
–
Gross Profit TTM
4 077 000 USD
Earnings per share
-0.15 USD
Diluted Eps TTM
-0.15 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-5.06 %
Dividend Analytics RMTI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History RMTI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:11
Payout Ratio
–
Last Split Date
13.05.2022
Dividend Date
–
Stock Valuation RMTI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
62.8931
Enterprise Value Revenue
1.4767
Price Sales TTM
1.4566
Enterprise Value EBITDA
-0.6475
Price Book MRQ
5.8236
Financials RMTI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators RMTI
For 52 weeks
1.16 USD
5.15 USD
50 Day MA
3.69 USD
Shares Short Prior Month
526 968
200 Day MA
2.24 USD
Short Ratio
1.51
Shares Short
823 372
Short Percent
2.67 %
BeatStart